BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38516860)

  • 1. Helicobacter pylori enhances HLA-C expression in the human gastric adenocarcinoma cells AGS and can protect them from the cytotoxicity of natural killer cells.
    Apoorva E; Jacob R; Rao DN; Kumar S
    Helicobacter; 2024; 29(2):e13069. PubMed ID: 38516860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
    Pittari G; Liu XR; Selvakumar A; Zhao Z; Merino E; Huse M; Chewning JH; Hsu KC; Dupont B
    J Immunol; 2013 May; 190(9):4650-60. PubMed ID: 23554313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4.
    Katz G; Markel G; Mizrahi S; Arnon TI; Mandelboim O
    J Immunol; 2001 Jun; 166(12):7260-7. PubMed ID: 11390475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model.
    van Bergen J; Thompson A; van Pel M; Retière C; Salvatori D; Raulet DH; Trowsdale J; Koning F
    J Immunol; 2013 Mar; 190(6):2880-5. PubMed ID: 23390293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
    Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional inhibitory human leucocyte antigen class I receptors on natural killer (NK) cells in patients with chronic NK lymphocytosis.
    Warren HS; Christiansen FT; Witt CS
    Br J Haematol; 2003 Jun; 121(5):793-804. PubMed ID: 12780796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch.
    Vampa ML; Norman PJ; Burnapp L; Vaughan RW; Sacks SH; Wong W
    Transplantation; 2003 Oct; 76(8):1220-8. PubMed ID: 14578757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
    Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
    J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.
    Fauriat C; Ivarsson MA; Ljunggren HG; Malmberg KJ; Michaëlsson J
    Blood; 2010 Feb; 115(6):1166-74. PubMed ID: 19903900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.
    Du Z; Gjertson DW; Reed EF; Rajalingam R
    Immunogenetics; 2007 Jan; 59(1):1-15. PubMed ID: 17103212
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Yang JS; Kang CY; Su CH; Chen CJ; Chiu YJ; Hsu YM
    Anticancer Res; 2022 Jan; 42(1):531-546. PubMed ID: 34969763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals.
    Foley B; De Santis D; Lathbury L; Christiansen F; Witt C
    Int Immunol; 2008 Apr; 20(4):555-63. PubMed ID: 18308713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity.
    Rajagopalan S; Long EO
    J Exp Med; 1997 Apr; 185(8):1523-8. PubMed ID: 9126935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.
    Mingari MC; Vitale C; Cambiaggi A; Schiavetti F; Melioli G; Ferrini S; Poggi A
    Int Immunol; 1995 Apr; 7(4):697-703. PubMed ID: 7547697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
    Bakker AB; Phillips JH; Figdor CG; Lanier LL
    J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.